Sanofi SA Grants CFAO Healthcare Exclusive Rights To Distribute Its General Medicines Range In Nigeria

Sanofi SA, a leading global pharmaceutical company has granted CFAO Healthcare, a subsidiary of the French conglomerate CFAO Group the exclusive right to distribute the Sanofi General Medicines range in Nigeria.

This move is part of their joint efforts to enhance the pharmaceutical sector in Nigeria, Africa’s most populous country.

Jean-Marc Leccia, CEO & Chairman of CFAO Healthcare, expressed his delight, stating, “We are delighted to expand our partnership with Sanofi by extending the exclusive distribution of general medicines in Nigeria. CFAO Healthcare is actively strengthening its presence in the Nigerian market to respond effectively to the growing healthcare needs of the population and to secure access to quality medicines.”

The company stated that from February 2024, the commercialization of the Sanofi portfolio of medicines will transition to a third-party distribution model.

Sanofi’s shift was seen as a broader trend where health multinational companies operating in Nigeria are compelled to adopt business models as a response to the country’s economic realities.

This development is coming on the heels of the plans by GlaxoSmithKline to leave the country while also moving to a third-party distribution model.